my Risk Hereditary Cancer test
GPTKB entity
Statements (52)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:Genetics
|
| gptkbp:can_lead_to |
early detection
increased surveillance preventive surgery |
| gptkbp:can_provide |
informed decision making
|
| gptkbp:covered_by |
health insurance plans
|
| gptkbp:developed_by |
gptkb:Myriad_Genetics
|
| https://www.w3.org/2000/01/rdf-schema#label |
my Risk Hereditary Cancer test
|
| gptkbp:is_associated_with |
improved patient outcomes
reduced cancer mortality |
| gptkbp:is_available_in |
gptkb:Europe
gptkb:Canada gptkb:United_States |
| gptkbp:is_based_on |
DNA analysis
|
| gptkbp:is_considered |
standard of care
|
| gptkbp:is_discussed_in |
gptkb:literature
|
| gptkbp:is_evaluated_by |
clinical utility
reliability accuracy |
| gptkbp:is_part_of |
personalized medicine
preventive healthcare cancer risk assessment cancer genetics |
| gptkbp:is_promoted_by |
patient advocacy groups
|
| gptkbp:is_recognized_by |
high-risk individuals
low-risk individuals moderate-risk individuals |
| gptkbp:is_recommended_by |
gptkb:guidelines
|
| gptkbp:is_recommended_for |
individuals with family history of cancer
|
| gptkbp:is_subject_to |
regulatory oversight
|
| gptkbp:is_tested_for |
gptkb:Lynch_syndrome
gptkb:BRCA2 gptkb:BRCA1 PTEN mutations hereditary cancer syndromes TP53 mutations |
| gptkbp:is_used_by |
healthcare providers
|
| gptkbp:is_used_for |
family planning
treatment planning cancer prevention |
| gptkbp:is_used_in |
clinical trials
|
| gptkbp:performed_by |
laboratories
|
| gptkbp:provides_information_on |
genetic mutations
|
| gptkbp:requires |
genetic counseling
|
| gptkbp:results_may_impact |
preventive measures
treatment options screening recommendations |
| gptkbp:results_provided_in |
weeks
|
| gptkbp:sampled_in |
gptkb:blood
saliva |
| gptkbp:used_for |
risk assessment
|
| gptkbp:wildlife |
gptkb:true
|